Author: Vandana Singh

[ad_1] Quest Diagnostics Inc DGX posted a better-than-expected Q2 FY22 adjusted EPS of $2.36, though down 25.8% Y/Y, beating the consensus of $2.20. Sales came in at $2.45 billion, a…

[ad_1] Biogen Inc BIIB has posted Q2 sales of $2.59 billion, beating the consensus of $2.48 billion, down 7% Y/Y and 5% at constant currency (CC). Multiple sclerosis revenue, including…

[ad_1] The DEKRA Notified Body has approved the use of Nyxoah SA’s NYXH next-generation Genio 2.1 system for patients in Europe.  Genio 2.1 is a patient-centered, leadless, and battery-free hypoglossal neurostimulation therapy…